NCT07030036Not yet recruiting
Screening for Cognitive Disorders in Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 19 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to identify cognitive problems in adults with multiple sclerosis (MS). MS can affect memory, thinking speed, and spatial skills, which may impact daily life and work. We will use simple and proven tests to check for these difficulties and see how they affect quality of life. The study will include about 60 patients followed at the neurology day hospital.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 12 Jun 2025
- Start date
- 15 Jul 2025
- Primary completion date
- 15 Nov 2025
- Lead sponsor
- Centre Hospitalier de Gonesse
- Diseases
- Multiple sclerosis
- NCT number
- NCT07030036
What you commit to
- Study type: Observational
- Planned participants: 60
- From 15 Jul 2025 to the primary completion date, 15 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- \- Under 18 years old
Who the study is looking for
- Patients aged 18 years or older
- Diagnosed with multiple sclerosis (MS) for at least 6 months according to the 2017 McDonald criteria (SFSEP)
- Receiving disease-modifying treatment and followed in the neurology day hospital of CH Gonesse
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| France Coordinator of this site? Confirm its status | Gonesse | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.